Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2019-07-13 2019-04-29
Drug Identification Number 02239208 02239208
Brand name PRIORIX PRIORIX
Common or Proper name Combined measles, mumps and rubella vaccine, live, attenuated Combined measles, mumps and rubella vaccine, live, attenuated
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients MUMPS VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED WATER MUMPS VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED WATER
Strength(s) 10000UNIT 1000UNIT 1000UNIT 0.5ML 10000UNIT 1000UNIT 1000UNIT 0.5ML
Dosage form(s) KIT POWDER FOR SOLUTION KIT POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 10's 10's
ATC code J07BD J07BD
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-04-24 2019-04-24
Estimated end date 2019-07-12 2019-07-12
Actual end date 2019-07-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100. Delay in supply of Diluent required for use with Vaccine.
Health Canada comments